FDA says three atypical antipsychotic medications may be effective in children, but carry risks.

Monday, June 8th, 2009

The Wall Street Journal (6/5, Dooren) reported that on June 5, staff from the Food and Drug Administration (FDA) said that three medications “currently approved to treat bipolar disorder and schizophrenia in adults were effective at treating the disorders in children and adolescents, but carry significant risks.” The FDA is now “considering applications (pdf) for […]